Schedule 13G ownership disclosure

Xenon Pharmaceuticals Inc

Security class unavailable · CUSIP: 98420N105

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,900,900
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000858744-19-000023
Form type
SC 13G
Filer
SMALLCAP WORLD FUND INC
CIK
CIK 858744
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub